Moore MB - Search Results

1

The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer.

Harpole DH Jr, Moore MB, Herndon JE 2nd, Aloia T, D'Amico TA, Sporn T, Parr A, Linoila I, Allegra C. Harpole DH Jr, et al. Among authors: moore mb. Clin Cancer Res. 2001 Mar;7(3):562-9. Clin Cancer Res. 2001. PMID: 11297249

2

A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers.

D'Amico TA, Massey M, Herndon JE 2nd, Moore MB, Harpole DH Jr. D'Amico TA, et al. Among authors: moore mb. J Thorac Cardiovasc Surg. 1999 Apr;117(4):736-43. doi: 10.1016/s0022-5223(99)70294-1. J Thorac Cardiovasc Surg. 1999. PMID: 10096969 Free article.

3

Tumor marker expression is predictive of survival in patients with esophageal cancer.

Aloia TA, Harpole DH Jr, Reed CE, Allegra C, Moore MB, Herndon JE 2nd, D'Amico TA. Aloia TA, et al. Among authors: moore mb. Ann Thorac Surg. 2001 Sep;72(3):859-66. doi: 10.1016/s0003-4975(01)02838-7. Ann Thorac Surg. 2001. PMID: 11565671

4

Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.

Kinch MS, Moore MB, Harpole DH Jr. Kinch MS, et al. Among authors: moore mb. Clin Cancer Res. 2003 Feb;9(2):613-8. Clin Cancer Res. 2003. PMID: 12576426

5

Molecular biologic substaging of stage I lung cancer according to gender and histology.

D'Amico TA, Aloia TA, Moore MB, Herndon JE 2nd, Brooks KR, Lau CL, Harpole DH Jr. D'Amico TA, et al. Among authors: moore mb. Ann Thorac Surg. 2000 Mar;69(3):882-6. doi: 10.1016/s0003-4975(99)01522-2. Ann Thorac Surg. 2000. PMID: 10750777

6

Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer.

Marom EM, Aloia TA, Moore MB, Hara M, Herndon JE 2nd, Harpole DH Jr, Goodman PC, Patz EF Jr. Marom EM, et al. Among authors: moore mb. Lung Cancer. 2001 Aug-Sep;33(2-3):99-107. doi: 10.1016/s0169-5002(00)00250-6. Lung Cancer. 2001. PMID: 11551404

7

Predicting the sites of metastases from lung cancer using molecular biologic markers.

D'Amico TA, Aloia TA, Moore MB, Conlon DH, Herndon JE 2nd, Kinch MS, Harpole DH Jr. D'Amico TA, et al. Among authors: moore mb. Ann Thorac Surg. 2001 Oct;72(4):1144-8. doi: 10.1016/s0003-4975(01)02979-4. Ann Thorac Surg. 2001. PMID: 11603427

8

Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy.

Harris LN, Liotcheva V, Broadwater G, Ramirez MJ, Maimonis P, Anderson S, Everett T, Harpole D, Moore MB, Berry DA, Rizzeri D, Vredenburgh JJ, Bentley RC. Harris LN, et al. Among authors: moore mb. J Clin Oncol. 2001 Mar 15;19(6):1698-706. doi: 10.1200/JCO.2001.19.6.1698. J Clin Oncol. 2001. PMID: 11250999

9

Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.

Kawakami K, Brabender J, Lord RV, Groshen S, Greenwald BD, Krasna MJ, Yin J, Fleisher AS, Abraham JM, Beer DG, Sidransky D, Huss HT, Demeester TR, Eads C, Laird PW, Ilson DH, Kelsen DP, Harpole D, Moore MB, Danenberg KD, Danenberg PV, Meltzer SJ. Kawakami K, et al. Among authors: moore mb. J Natl Cancer Inst. 2000 Nov 15;92(22):1805-11. doi: 10.1093/jnci/92.22.1805. J Natl Cancer Inst. 2000. PMID: 11078757

10

Percutaneous cecostomy: 25-year two institution experience.

James CA, Hogan MJ, Seay RP, James LT, Jensen HK, Kaukis NA, Moore MB, Braswell LE. James CA, et al. Among authors: moore mb. Pediatr Radiol. 2024 May 2. doi: 10.1007/s00247-024-05936-2. Online ahead of print. Pediatr Radiol. 2024. PMID: 38693250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page